IMMUNOGENIC COMPOSITION FOR USE IN THERAPY

The application discloses a method of immunising against Staphylococcus aureus infection comprising a step of administering to a human patient a single dose of an immunogenic composition comprising a Staphylococcus aureus Type 5 capsular saccharide conjugated to a carrier protein to form a S. aureus...

Full description

Saved in:
Bibliographic Details
Main Authors BIEMANS, RALPH LEON, DUVIVIER, PIERRE, GORAJ, CARINE, BOUTRIAU, DOMINIQUE, DENOEL, PHILIPPE
Format Patent
LanguageEnglish
French
Published 17.01.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The application discloses a method of immunising against Staphylococcus aureus infection comprising a step of administering to a human patient a single dose of an immunogenic composition comprising a Staphylococcus aureus Type 5 capsular saccharide conjugated to a carrier protein to form a S. aureus Type 5 capsular saccharide conjugate, wherein the S. aureus Type 5 capsular saccharide conjugate is administered at a saccharide dose of 3- 50µg. La demande concerne un procédé d'immunisation contre une infection par Staphylococcus aureus comprenant une étape d'administration à un patient humain d'une dose unique d'une composition immunogène comprenant un saccharide de capsule de type 5 de Staphylococcus aureus conjugué à une protéine support pour former un conjugué saccharide de capsule de type 5 de S. aureus, le conjugué saccharide de capsule de type 5 de S. aureus étant administré à une dose de saccharide de 3-50 µg.
Bibliography:Application Number: CA20142912496